FDA Investigator

Anna M Spiros

Latest inspection on record: Dayton, United States, April 2026 · records back to 2024

Human DrugsAnimal Drugs & Feeds

FDA inspection record · Last updated July 12, 2026

Overview

  • 20 inspections across 20 sites are on record.
  • 40 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-04-28.

At a glance

Inspections

20

Sites

20

Observations

40

Career since

Oct 2024

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Geer Gas Corporation28 Apr 2026Human DrugsOn file
GOJO Industries LLC9 Apr 2026Human DrugsOn file
Teva Womens Health, LLC20 Mar 2026Human DrugsOn file
Nippon Sanso Matheson, Inc.11 Feb 2026Human Drugs
Air Products and Chemicals Inc29 Jan 2026Human Drugs

Sites inspected

Geer Gas CorporationDayton, United States1 insp.
GOJO Industries LLCCuyahoga Falls, United States1 insp.
Teva Womens Health, LLCCincinnati, United States1 insp.
Nippon Sanso Matheson, Inc.Holland, United States1 insp.
Air Products and Chemicals IncMiddletown, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Jacob G Lutz3 shared
Jordan S Burkdoll2 shared
Abigail Sundberg1 shared
WenNing Chan1 shared
Elizabeth R Bloom1 shared
Ana-Maria A Plapcianu1 shared

Full investigator report

Get the verbatim findings behind Anna M Spiros' 40 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators